Recent Quarter Total Invested
$136.46 M
Recent Quarter Institutional Ownership Percentage
43.17%
Total Invested of Last Quarter
$133.96 M
Ownership Percentage of Last Quarter
43.14%
Xeris Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 10.33 M | $23.25 M | 3.73% | 7.35% |
| VANGUARD GROUP INC | 08/13/2024 | 7.66 M | $17.23 M | 0.67% | 5.45% |
| CAXTON CORP | 08/14/2024 | 5.11 M | $11.51 M | 0.00% | 3.64% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 4.83 M | $10.87 M | 15.94% | 3.44% |
| STATE STREET CORP | 08/14/2024 | 3.26 M | $7.33 M | 1.36% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 3.24 M | $7.29 M | 6.40% | 2.31% |
| ROSALIND ADVISORS, INC. | 07/12/2024 | 3.12 M | $7.02 M | 10.64% | 2.22% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.70 M | $3.82 M | 0.05% | 1.21% |
| MORGAN STANLEY | 08/14/2024 | 1.61 M | $3.62 M | 24.71% | 1.15% |
| CENTERBOOK PARTNERS LP | 08/12/2024 | 1.47 M | $3.30 M | -5.05% | 1.04% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 1.35 M | $3.04 M | 33.91% | 0.96% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 1.34 M | $3.02 M | -15.59% | 0.96% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.19 M | $2.68 M | 4.56% | 0.85% |
| NORTHERN TRUST CORP | 08/14/2024 | 1.11 M | $2.49 M | -4.52% | 0.79% |
| REDMILE GROUP, LLC | 08/14/2024 | 1.05 M | $2.35 M | 0.00% | 0.74% |
| KNOTT DAVID M JR | 08/12/2024 | 820,000 | $1.85 M | 36.67% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 641,666 | $1.44 M | 2.17% | 0.46% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2024 | 636,244 | $1.43 M | 51.31% | 0.45% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 605,663 | $1.36 M | 5,071.74% | 0.43% |
| INVENOMIC CAPITAL MANAGEMENT LP | 08/14/2024 | 592,078 | $1.33 M | -2.06% | 0.42% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2024 | 573,186 | $1.29 M | 0.00% | 0.41% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 518,024 | $1.17 M | -26.73% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 428,554 | $964,246 | 22.96% | 0.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 422,109 | $949,746 | 6.34% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 404,582 | $910,310 | 10.45% | 0.29% |
| JANE STREET GROUP, LLC | 08/15/2024 | 347,592 | $782,082 | 51.15% | 0.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 336,047 | $756,105 | 15.68% | 0.24% |
| JPMORGAN CHASE & CO | 08/12/2024 | 324,403 | $729,906 | -13.34% | 0.23% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 315,664 | $710,244 | 25.54% | 0.22% |
| ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 300,000 | $675,000 | 0.00% | 0.21% |
| IHT WEALTH MANAGEMENT, LLC | 08/14/2024 | 296,335 | $666,771 | -0.68% | 0.21% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 219,906 | $494,788 | -76.93% | 0.16% |
| BROWN ADVISORY INC | 08/14/2024 | 190,255 | $428,074 | 0.00% | 0.14% |
| RHUMBLINE ADVISERS | 08/01/2024 | 189,970 | $427,423 | 6.94% | 0.14% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/31/2024 | 187,003 | $421,000 | 0.00% | 0.13% |
| DIVERSIFIED TRUST CO | 07/16/2024 | 175,739 | $395,412 | 0.00% | 0.13% |
| BARCLAYS PLC | 08/14/2024 | 172,787 | $389,000 | -15.70% | 0.12% |
| THOMPSON SIEGEL & WALMSLEY LLC | 08/08/2024 | 172,784 | $389,000 | -9.06% | 0.12% |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 08/14/2024 | 170,937 | $382,899 | 12.91% | 0.12% |
| UBS GROUP AG | 08/14/2024 | 163,639 | $368,189 | -16.77% | 0.12% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 147,720 | $332,370 | 83.69% | 0.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 130,968 | $295,000 | 4.24% | 0.09% |
| CETERA INVESTMENT ADVISERS | 08/22/2024 | 118,443 | $266,497 | -0.10% | 0.08% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 100,830 | $226,868 | 0.15% | 0.07% |
| CITADEL ADVISORS LLC | 08/14/2024 | 88,500 | $199,125 | 34.70% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2024 | 82,638 | $185,936 | 42.25% | 0.06% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 80,420 | $180,945 | 0.00% | 0.06% |
| PRINCIPAL FINANCIAL GROUP INC | 07/29/2024 | 78,626 | $176,909 | -12.27% | 0.06% |
| SIGMA PLANNING CORP | 08/06/2024 | 78,450 | $176,513 | 2.48% | 0.06% |
| COREBRIDGE FINANCIAL, INC. | 08/14/2024 | 75,441 | $169,742 | 100.00% | 0.05% |
Xeris Biopharma Holdings, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XERS shares?
During the previous two years, 164 institutional investors and hedge funds held shares of Xeris Biopharma Holdings, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 10.33 M
VANGUARD GROUP INC: 7.66 M
CAXTON CORP: 5.11 M
BioImpact Capital LLC: 4.83 M
STATE STREET CORP: 3.26 M
GEODE CAPITAL MANAGEMENT, LLC: 3.24 M
-
What percentage of Xeris Biopharma Holdings, Inc. stock is owned by institutional investors?
43.17% of Xeris Biopharma Holdings, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at XERS ?
Institutional investors have bought a total of 61.78 M shares in the last 24 months. This purchase volume represents approximately $179.78 M in transactions.